NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

Speaking of the Steering Committee member, Dr. Steven Brem, who is a graduate of Harvard Medical School, and he is the Professor and Chief of Neurosurgical Oncology in the Department of Neurosurgery at Penn Medicine, University of Pennsylvania, I am reminded of this interview he gave back in 2019 talking about the DCVax-L Phase III trial, and his hope that DCVax-L will be approved by the FDA. Listen closely starting at the 1:52 minute mark to the 3:15 minute mark.

Unlike LC & Ex, Dr. Liau, Dr. Ashkan and Dr. Brem believe in DCVax. Who do you believe?